A citation-based method for searching scientific literature

Jon B Toledo, Matthias Arnold, Gabi Kastenmüller, Rui Chang, Rebecca A Baillie, Xianlin Han, Madhav Thambisetty, Jessica D Tenenbaum, Karsten Suhre, J Will Thompson, Lisa St John-Williams, Siamak MahmoudianDehkordi, Daniel M Rotroff, John R Jack, Alison Motsinger-Reif, Shannon L Risacher, Colette Blach, Joseph E Lucas, Tyler Massaro, Gregory Louie, Hongjie Zhu, Guido Dallmann, Kristaps Klavins, Therese Koal, Sungeun Kim, Kwangsik Nho, Li Shen, Ramon Casanova, Sudhir Varma, Cristina Legido-Quigley, M Arthur Moseley, Kuixi Zhu, Marc Y R Henrion, Sven J van der Lee, Amy C Harms, Ayse Demirkan, Thomas Hankemeier, Cornelia M van Duijn, John Q Trojanowski, Leslie M Shaw, Andrew J Saykin, Michael W Weiner, P Murali Doraiswamy, Rima Kaddurah-Daouk. Alzheimers Dement 2017
Times Cited: 188







List of co-cited articles
920 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Vijay R Varma, Anup M Oommen, Sudhir Varma, Ramon Casanova, Yang An, Ryan M Andrews, Richard O'Brien, Olga Pletnikova, Juan C Troncoso, Jon Toledo,[...]. PLoS Med 2018
188
35

Plasma phospholipids identify antecedent memory impairment in older adults.
Mark Mapstone, Amrita K Cheema, Massimo S Fiandaca, Xiaogang Zhong, Timothy R Mhyre, Linda H MacArthur, William J Hall, Susan G Fisher, Derick R Peterson, James M Haley,[...]. Nat Med 2014
657
27

Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.
Juho Tynkkynen, Vincent Chouraki, Sven J van der Lee, Jussi Hernesniemi, Qiong Yang, Shuo Li, Alexa Beiser, Martin G Larson, Katri Sääksjärvi, Martin J Shipley,[...]. Alzheimers Dement 2018
93
25

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
Eugenia Trushina, Tumpa Dutta, Xuan-Mai T Persson, Michelle M Mielke, Ronald C Petersen. PLoS One 2013
259
15

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.
Luke Whiley, Arundhuti Sen, James Heaton, Petroula Proitsi, Diego García-Gómez, Rufina Leung, Norman Smith, Madhav Thambisetty, Iwona Kloszewska, Patrizia Mecocci,[...]. Neurobiol Aging 2014
168
14

Metabolome in progression to Alzheimer's disease.
M Orešič, T Hyötyläinen, S-K Herukka, M Sysi-Aho, I Mattila, T Seppänan-Laakso, V Julkunen, P V Gopalacharyulu, M Hallikainen, J Koikkalainen,[...]. Transl Psychiatry 2011
178
14

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.
Ramon Casanova, Sudhir Varma, Brittany Simpson, Min Kim, Yang An, Santiago Saldana, Carlos Riveros, Pablo Moscato, Michael Griswold, Denise Sonntag,[...]. Alzheimers Dement 2016
98
14

Application of Metabolomics in Alzheimer's Disease.
Jordan Maximillian Wilkins, Eugenia Trushina. Front Neurol 2018
110
14

Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease.
Stewart F Graham, Olivier P Chevallier, Christopher T Elliott, Christian Hölscher, Janet Johnston, Bernadette McGuinness, Patrick G Kehoe, Anthony Peter Passmore, Brian D Green. PLoS One 2015
97
12

Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
Kwangsik Nho, Alexandra Kueider-Paisley, Siamak MahmoudianDehkordi, Matthias Arnold, Shannon L Risacher, Gregory Louie, Colette Blach, Rebecca Baillie, Xianlin Han, Gabi Kastenmüller,[...]. Alzheimers Dement 2019
92
11

Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study.
Stuart G Snowden, Amera A Ebshiana, Abdul Hye, Yang An, Olga Pletnikova, Richard O'Brien, John Troncoso, Cristina Legido-Quigley, Madhav Thambisetty. PLoS Med 2017
143
10

The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment.
Kristaps Klavins, Therese Koal, Guido Dallmann, Josef Marksteiner, Georg Kemmler, Christian Humpel. Alzheimers Dement (Amst) 2015
63
15

Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
Giuseppe Paglia, Matteo Stocchero, Stefano Cacciatore, Steven Lai, Peggi Angel, Mohammad Tauqeer Alam, Markus Keller, Markus Ralser, Giuseppe Astarita. J Proteome Res 2016
72
13

Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's Disease.
Massimo S Fiandaca, Xiaogang Zhong, Amrita K Cheema, Michael H Orquiza, Swathi Chidambaram, Ming T Tan, Carole Roan Gresenz, Kevin T FitzGerald, Mike A Nalls, Andrew B Singleton,[...]. Front Neurol 2015
74
13

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.
Xianlin Han, Steve Rozen, Stephen H Boyle, Caroline Hellegers, Hua Cheng, James R Burke, Kathleen A Welsh-Bohmer, P Murali Doraiswamy, Rima Kaddurah-Daouk. PLoS One 2011
258
10

Metabolomics in the Development and Progression of Dementia: A Systematic Review.
Yanfeng Jiang, Zhen Zhu, Jie Shi, Yanpeng An, Kexun Zhang, Yingzhe Wang, Shuyuan Li, Li Jin, Weimin Ye, Mei Cui,[...]. Front Neurosci 2019
36
27

Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling.
Huajie Li, Dan Ye, Wei Xie, Fei Hua, Yilin Yang, Jian Wu, Aifang Gu, Yi Ren, Keshi Mao. Biosci Rep 2018
31
29

Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
Siamak MahmoudianDehkordi, Matthias Arnold, Kwangsik Nho, Shahzad Ahmad, Wei Jia, Guoxiang Xie, Gregory Louie, Alexandra Kueider-Paisley, M Arthur Moseley, J Will Thompson,[...]. Alzheimers Dement 2019
198
9

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
9

Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's disease.
Raúl González-Domínguez, Tamara García-Barrera, José Luis Gómez-Ariza. J Pharm Biomed Anal 2015
94
9

Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome.
Matthias Arnold, Kwangsik Nho, Alexandra Kueider-Paisley, Tyler Massaro, Kevin Huynh, Barbara Brauner, Siamak MahmoudianDehkordi, Gregory Louie, M Arthur Moseley, J Will Thompson,[...]. Nat Commun 2020
43
20

Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
Zhiguang Huo, Lei Yu, Jingyun Yang, Yun Zhu, David A Bennett, Jinying Zhao. Neurobiol Aging 2020
31
29

Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
Petroula Proitsi, Min Kim, Luke Whiley, Andrew Simmons, Martina Sattlecker, Latha Velayudhan, Michelle K Lupton, Hillka Soininen, Iwona Kloszewska, Patrizia Mecocci,[...]. Alzheimers Dement 2017
82
9

HMDB 4.0: the human metabolome database for 2018.
David S Wishart, Yannick Djoumbou Feunang, Ana Marcu, An Chi Guo, Kevin Liang, Rosa Vázquez-Fresno, Tanvir Sajed, Daniel Johnson, Carin Li, Naama Karu,[...]. Nucleic Acids Res 2018
8

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance.
Christopher B Newgard, Jie An, James R Bain, Michael J Muehlbauer, Robert D Stevens, Lillian F Lien, Andrea M Haqq, Svati H Shah, Michelle Arlotto, Cris A Slentz,[...]. Cell Metab 2009
8

Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjects.
H Basun, L G Forssell, O Almkvist, R F Cowburn, R Eklöf, B Winblad, L Wetterberg. J Neural Transm Park Dis Dement Sect 1990
49
16

Systemic and central nervous system metabolic alterations in Alzheimer's disease.
Vera van der Velpen, Tony Teav, Héctor Gallart-Ayala, Florence Mehl, Ioana Konz, Christopher Clark, Aikaterini Oikonomidi, Gwendoline Peyratout, Hugues Henry, Mauro Delorenzi,[...]. Alzheimers Res Ther 2019
54
14


Brain metabolic dysfunction at the core of Alzheimer's disease.
Suzanne M de la Monte, Ming Tong. Biochem Pharmacol 2014
266
7


Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
Carmen Peña-Bautista, Marta Roca, David Hervás, Ana Cuevas, Rogelio López-Cuevas, Máximo Vento, Miguel Baquero, Ana García-Blanco, Consuelo Cháfer-Pericás. J Proteomics 2019
30
23

Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease.
P Proitsi, M Kim, L Whiley, M Pritchard, R Leung, H Soininen, I Kloszewska, P Mecocci, M Tsolaki, B Vellas,[...]. Transl Psychiatry 2015
74
9

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort.
Lisa St John-Williams, Colette Blach, Jon B Toledo, Daniel M Rotroff, Sungeun Kim, Kristaps Klavins, Rebecca Baillie, Xianlin Han, Siamak Mahmoudiandehkordi, John Jack,[...]. Sci Data 2017
26
26

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
7

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
7

Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease.
D Allan Butterfield, Barry Halliwell. Nat Rev Neurosci 2019
476
7

Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?
Jeddidiah W D Griffin, Patrick C Bradshaw. Oxid Med Cell Longev 2017
66
10

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS).
Danni Li, Jeffrey R Misialek, Eric Boerwinkle, Rebecca F Gottesman, A Richey Sharrett, Thomas H Mosley, Josef Coresh, Lisa M Wruck, David S Knopman, Alvaro Alonso. Alzheimers Dement (Amst) 2016
43
16

Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis.
Xianlin Han, David M Holtzman, Daniel W McKeel, John Kelley, John C Morris. J Neurochem 2002
408
6

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
6

Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.
Gang Wang, Yi Zhou, Feng-Jie Huang, Hui-Dong Tang, Xu-Hua Xu, Jia-Jian Liu, Ying Wang, Yu-Lei Deng, Ru-Jing Ren, Wei Xu,[...]. J Proteome Res 2014
85
7

A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease.
Chia-Ni Lin, Chin-Chang Huang, Kuo-Lun Huang, Kun-Ju Lin, Tzu-Chen Yen, Hung-Chou Kuo. Ann Clin Transl Neurol 2019
17
35

Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II.
Michelle M Mielke, Veera Vankata Ratnam Bandaru, Norman J Haughey, Jin Xia, Linda P Fried, Sevil Yasar, Marilyn Albert, Vijay Varma, Greg Harris, Eric B Schneider,[...]. Neurology 2012
130
6

Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
Min Kim, Alejo Nevado-Holgado, Luke Whiley, Stuart G Snowden, Hilkka Soininen, Iwona Kloszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, Madhav Thambisetty,[...]. J Alzheimers Dis 2017
44
13

Multi-omics approaches to disease.
Yehudit Hasin, Marcus Seldin, Aldons Lusis. Genome Biol 2017
653
6

Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study.
Danni Li, Jeffrey R Misialek, Eric Boerwinkle, Rebecca F Gottesman, A Richey Sharrett, Thomas H Mosley, Josef Coresh, Lisa M Wruck, David S Knopman, Alvaro Alonso. Alzheimers Dement (Amst) 2016
24
25

MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis.
Jasmine Chong, Othman Soufan, Carin Li, Iurie Caraus, Shuzhao Li, Guillaume Bourque, David S Wishart, Jianguo Xia. Nucleic Acids Res 2018
6

High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Akinori Nakamura, Naoki Kaneko, Victor L Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe,[...]. Nature 2018
664
6


Serum Levels of Acyl-Carnitines along the Continuum from Normal to Alzheimer's Dementia.
Adriana Cristofano, Nadia Sapere, Giancarlo La Marca, Antonella Angiolillo, Michela Vitale, Graziamaria Corbi, Giovanni Scapagnini, Mariano Intrieri, Claudio Russo, Gaetano Corso,[...]. PLoS One 2016
39
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.